Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells

Oncogene

Volumn 23, Issue 1, 2004, Pages 260-266

  Claij, Nanna ^a   Te Riele, Hein ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Cisplatin; Cre lox; Mismatch repair; MSH2

Indexed keywords

METHYLNITRONITROSOGUANIDINE; PROTEIN MSH2;

ANIMAL CELL; ARTICLE; CELL CLONE; CELL LINE; CELL POPULATION; CLONOGENIC ASSAY; CONTROLLED STUDY; DRUG SENSITIZATION; GENE INACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS; BASE PAIR MISMATCH; CARRIER PROTEINS; CISPLATIN; DNA REPAIR; DNA-BINDING PROTEINS; DRUG RESISTANCE; EMBRYO; INTEGRASES; METHYLNITRONITROSOGUANIDINE; MICE; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; STEM CELLS; VIRAL PROTEINS;

ANIMALIA;

EID: 0942301168     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207015     Document Type: Article

References (37)

1. Aebi S, Kurdi-Haidar B, Gordon R, Cenni B, Zheng H, Fink D, Christen RD, Boland CR, Koi M, Fishel R and Howell SB. (1996). Cancer Res., 56, 3087-3090.
2. Anthoney DA, McIlwrath AJ, Gallagher WM, Edlin AR and Brown R. (1996). Cancer Res., 56, 1374-1381.
3. Aquilina G, Ceccotti S, Martinelli S, Soddu S, Crescenzi M, Branch P, Karran P and Bignami M. (2000). Clin. Cancer Res., 6, 671-680.
4. Branch P, Masson M, Aquilina G, Bignami M and Karran P. (2000). Oncogene, 19, 3138-3145.
5. Buermeyer AB, Wilson-Van Patten C, Baker SM and Liskay RM. (1999). Cancer Res., 59, 538-541.
6. Canitrot Y, Cazaux C, Frechet M, Bouayadi K, Lesca C, Salles B and Hoffmann JS. (1998). Proc. Natl. Acad. Sci. USA, 95, 12586-12590.
7. Claij N and Te Riele H. (2002). Oncogene, 21, 2873-2879.
8. de Wind N, Dekker M, Berns A, Radman M and Te Riele H. (1995). Cell, 82, 321-330.
9. de Wind N, Dekker M, van Rossum A, van der Valk M and Te Riele H. (1998). Cancer Res., 58, 248-255.
10. Drummond JT, Anthoney A, Brown R and Modrich P. (1996). J. Biol. Chem., 271, 19645-19648.
11. Duckett DR, Drummond JT, Murchie AI, Reardon JT, Sancar A, Lilley DM and Modrich P. (1996). Proc. Natl. Acad. Sci. USA, 93, 6443-6447.
12. Durant ST, Morris MM, Illand M, McKay HJ, McCormick C, Hirst GL, Borts RH and Brown R. (1999). Curr. Biol., 9, 51-54.
13. Fink D, Nebel S, Aebi S, Zheng H, Cenni B, Nehme A, Christen RD and Howell SB. (1996). Cancer Res., 56, 4881-4886.
14. Fink D, Nebel S, Norris PS, Aebi S, Kim HK, Haas M and Howell SB. (1998). Br. J. Cancer, 77, 703-708.
15. Fink D, Zheng H, Nebel S, Norris PS, Aebi S, Lin TP, Nehme A, Christen RD, Haas M, MacLeod CL and Howell SB. (1997). Cancer Res., 57, 1841-1845.
16. Gong JG, Costanzo A, Yang HQ, Melino G, Kaelin Jr WG, Levrero M and Wang JY. (1999). Nature, 399, 806-809.
17. Hawn MT, Umar A, Carethers JM, Marra G, Kunkel TA, Boland CR and Koi M. (1995). Cancer Res., 55, 3721-3725.
18. Kartalou M and Essigmann JM. (2001). Mutat. Res., 478, 23-43.
19. Koi M, Umar A, Chauhan DP, Cherian SP, Carethers JM, Kunkel TA and Boland CR. (1994). Cancer Res., 54, 4308-4312.
20. Lan Z, Sever-Chroneos Z, Strobeck MW, Park CH, Baskaran R, Edelmann W, Leone G and Knudsen ES. (2002). J. Biol. Chem., 277, 8372-8381.
21. Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL and Chaney SG. (1994). Cancer Res., 54, 3500-3505.
22. Massey A, Offman J, Macpherson P and Karran P. (2003). DNA Repair, 2, 73-89.
23. Mello JA, Acharya S, Fishel R and Essigmann JM. (1996). Chem. Biol., 3, 579-589.
24. Mu D, Tursun M, Duckett DR, Drummond JT, Modrich P and Sancar A. (1997). Mol. Cell. Biol., 17, 760-769.
25. Nehme A, Baskaran R, Aebi S, Fink D, Nebel S, Cenni B, Wang JY, Howell SB and Christen RD. (1997). Cancer Res., 57, 3253-3257.
26. Risinger JI, Umar A, Barrett JC and Kunkel TA. (1995). J. Biol. Chem., 270, 18183-18186.
27. Samimi G, Fink D, Varki NM, Husain A, Hoskins WJ, Alberts DS and Howell SB. (2000). Clin. Cancer Res., 6, 1415-1421.
28. Sansom OJ and Clarke AR. (2002). Oncogene, 21, 5934-5939.
29. Sergent C, Franco N, Chapusot C, Lizard-Nacol S, Isambert N, Correia M and Chauffert B. (2002). Cancer Chemother. Pharmacol., 49, 445-452.
30. Siddik ZH, Mims B, Lozano G and Thai G. (1998). Cancer Res., 58, 698-703.
31. Strathdee G, Sansom OJ, Sim A, Clarke AR and Brown R. (2001). Oncogene, 20, 1923-1927.
32. Swann PF, Waters TR, Moulton DC, Xu Y-Z, Zheng Q, Edwards M and Mace R. (1996). Science, 273, 1109-1111.
33. Taniguchi M, Sanbo M, Watanabe S, Naruse I, Mishina M and Yagi T. (1998). Nucleic Acids Res., 26, 679-680.
34. Vaisman A, Varchenko M, Umar A, Kunkel TA, Risinger JI, Barrett JC, Hamilton TC and Chaney SG. (1998). Cancer Res., 58, 3579-3585.
35. Watanabe Y, Koi M, Hemmi H, Hoshai H and Noda K. (2001). Br. J. Cancer, 85, 1064-1069.
36. Yamada M, O'Regan E, Brown R and Karran P. (1997). Nucleic Acids Res., 25, 491-495.
37. Zhukovskaya N, Branch P, Aquilina G and Karran P. (1994). Carcinogenesis, 15, 2189-2194.